Aarti Pharmalabs shares hit the 20% upper circuit at Rs 823 on the BSE on Monday following the announcement of its June-quarter results. The sharp rally came after the company reported strong double-digit growth in revenue and net profit, along with key announcements on plant expansion and board-level management changes.